Target intelligence / Profile preview

Glutamate-ammonia ligase pseudogene 4 (GLULP4)

Target
GLULP4
Molecular classification
Other (Pseudogene)
01

Overview

GLULP4, or glutamate-ammonia ligase pseudogene 4, is a human pseudogene located on chromosome 9. It is derived from the glutamate-ammonia ligase (GLUL) gene—also known as glutamine synthetase—which encodes an enzyme critical for the ATP-dependent synthesis of glutamine from glutamate and ammonia in multisystem metabolism. However, GLULP4 does not encode a functional protein and is generally considered non-coding. This gene is classified as a pseudogene because it does not produce an active enzyme, and there are currently no recognized roles for GLULP4 in therapeutics, disease, or as a biomarker. Pseudogenes in general may occasionally exert gene regulatory effects (for example, as competitive endogenous RNAs or through effects on gene dosage), but no such function is specifically documented for GLULP4 in current literature. If you require information about the functional and clinically relevant glutamate-ammonia ligase (glutamine synthetase) gene instead (GLUL), please specify, as it is a distinct entity directly involved in glutamate/ammonia metabolism and several pathologies.

Other names
GLULPglutamate-ammonia ligase (glutamine synthase) pseudogeneglutamate-ammonia ligase (glutamine synthetase) pseudogene 4GLULP4
02

Biological functions

Other (No known protein function; pseudogene)
03

Disease associations

Other (No direct clinical or pathological disease role; pseudogenes sometimes have regulatory or evolutionary functions but none are specifically reported for GLULP4)

Beyond the preview

Go deeper on Glutamate-ammonia ligase pseudogene 4 (GLULP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate-ammonia ligase pseudogene 4 (GLULP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call